IP Library Granted Patent US 11,857,239
Granted Patent B2
US 11,857,239 · App. 16/259,609 · Granted Jan 2, 2024

Cryogenic needle with freeze zone regulation

Inventors: Michael Fourkas (Sunnyvale, CA); Ronald Williams (Menlo Park, CA); John Allison (Los Altos, CA); Jesse Rosen (Albany, CA)
Assignee: Pacira CryoTech, Inc.
A61B18/02A61B2017/00473A61B2018/00029A61B2018/00041A61B2018/00648A61B2018/00714A61B2018/00738A61B2018/00744A61B2018/00779A61B2018/00791A61B2018/00898A61B2018/00994A61B2018/0262A61B2018/0293
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,857,239
App. No.
16/259,609
Granted
Jan 2, 2024
Kind
B2
Abstract

A cryogenic needle of a cryogenic system is coupled to a heater. While the needle is inserted into target tissue beneath skin, the heater provides heat to protect the skin. Power supplied to the heater is used to interpolate performance of the needle and/or operating parameters of the cryogenic system.

Claims (25)

1. A method for cryogenically treating target tissue, the method comprising:

providing a needle probe having at least one needle with a distal portion and a proximal portion, the needle probe being coupled to a coolant supply system regulated by a valve, wherein the least one needle is advanced into the target tissue;

regulating the valve to provide the at least one needle probe with coolant to form a cooling zone in the target tissue;

providing power to a heater assembly of the needle probe to protect non-target tissue;

monitoring at least one characteristic of the heater assembly while providing the power to the heater assembly;

regulating coolant to the needle probe using the valve based on a correlation of the at least one monitored characteristic of the heater assembly and a tissue characteristic or an operating parameter.

2. The method of claim 1 , wherein the at least one monitored characteristic comprises temperature of the heater assembly.

3. The method of claim 1 , wherein the at least one monitored characteristic comprises the power supplied to the heater assembly.

4. The method of claim 1 , wherein regulating the coolant substantially maintains the cooling zone within an allowable size tolerance.

5. The method of claim 4 , wherein regulating the coolant comprises regulating the valve to halt or decrease the coolant flowing in the needle probe long enough for the cooling zone to decrease in size within the allowable size tolerance.

6. The method of claim 4 , wherein regulating the coolant comprises regulating the valve to increase the coolant flowing in the needle probe long enough for the cooling zone to increase in size within the allowable size tolerance.

7. The method of claim 4 , wherein the allowable size tolerance is determined by performing a tissue pre-characterization routine using the needle probe.

8. The method of claim 1 , wherein regulating the valve is based on a predetermined treatment algorithm.

9. The method of claim 1 , wherein the at least one characteristic of the heater assembly comprises at least one of a heater power, heat transfer rate, heat flux, temperature change rate, or temperature differential.

10. The method of claim 1 , further comprising providing a user indication based on the correlation.

11. The method of claim 10 , wherein the user indication comprises a tissue type.

12. The method of claim 10 , wherein the user indication comprises needle probe status.

13. The method of claim 10 , wherein the user indication comprises a malfunction of the valve.

14. The method of claim 13 , further comprising providing a user alert based on the malfunction.

15. The method of claim 1 , wherein the operating parameter comprises at least one of heat transfer rate, heat flux, temperature change rate, or temperature differential.

16. The method of claim 1 , wherein the tissue characteristic comprises a tissue type or depth of insertion of the at least one needle.

17. The method of claim 1 , wherein regulating the coolant to the needle probe comprises controlling a treatment time, rate of temperature change, coolant flow rate or temperature.

18. The method of claim 1 , wherein the at least one needle comprises a needle array.

19. The method of claim 1 , wherein the at least one needle comprises three needles.

20. The method of claim 19 , further comprising providing a user indication that one of the three needles is not working.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Dec 5, 2025
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 073779/0532 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 31, 2023
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 063213/0864 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Mar 31, 2023
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 063214/0108 →
SUPPLEMENTAL CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Dec 14, 2021
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; FLEXION THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058516/0636 →
CONFIRMATORY ASSIGNMENT Recorded Jul 15, 2019
From: MYOSCIENCE, INC.
To: PACIRA CRYOTECH, INC.
Reel/Frame 049758/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2019
From: FOURKAS, MICHAEL; WILLIAMS, RONALD; ALLISON, JOHN; ROSEN, JESSE
To: MYOSCIENCE, INC.
Reel/Frame 048159/0114 →
Cited By (1)
US 12,551,258